Multiple myeloma
- Resource Type
- Authors
- Jesús F. San-Miguel; U. Mey; Mario Boccadoro; Thierry Facon; Roman Hájek; P. Moreau; M.V. Mateos; E. Terpos; M.A. Dimopoulos; Michele Cavo; Fredrik Schjesvold; H. Goldschmidt; Gordon Cook; Michel Delforge; Sonja Zweegman; H. Einsele; Pieter Sonneveld
- Source
- EHA Guidelines Committee & ESMO Guidelines Committee 2021, ' Multiple myeloma : EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up † ', Annals of Oncology, vol. 32, no. 3, pp. 309-322 . https://doi.org/10.1016/j.annonc.2020.11.014
Annals of Oncology, 32(3), 309-322. Oxford University Press
Annals of Oncology, 32(3), 309-322. Elsevier Ltd.
Dimopoulos, M A, Moreau, P, Terpos, E, Mateos, M V, Zweegman, S, Cook, G, Delforge, M, Hájek, R, Schjesvold, F, Cavo, M, Goldschmidt, H, Facon, T, Einsele, H, Boccadoro, M, San-Miguel, J, Sonneveld, P & Mey, U 2021, ' Multiple Myeloma : EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up ', HemaSphere . https://doi.org/10.1097/HS9.0000000000000528
HemaSphere
- Subject
- Pediatrics
medicine.medical_specialty
MINIMAL RESIDUAL DISEASE
BORTEZOMIB
THERAPY
Follow-Up Studie
CONDITIONING REGIMEN
follow-up
ORAL IXAZOMIB
Medicine
Multiple myeloma
Societies, Medical
Science & Technology
treatment
INTERGROUPE FRANCOPHONE
business.industry
Follow up studies
STEM-CELL TRANSPLANTATION
Hematology
Guideline Article - Consensus based
medicine.disease
OPEN-LABEL
PHASE-III
Clinical Practice
multiple myeloma
diagnosi
Oncology
Diagnosis treatment
business
Life Sciences & Biomedicine
clinical practice guideline
prognosi
LENALIDOMIDE PLUS DEXAMETHASONE
Human
- Language
- English
- ISSN
- 1569-8041
0923-7534
2572-9241
ispartof: HEMASPHERE vol:5 issue:2 ispartof: location:United States status: published